Who Supplies Ceftazidime? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ceftazidime exports, with 228+ registered manufacturers shipping to buyers across 99+ countries — yet a handful of companies dominate the shipments. ZEISS PHARMACEUTICALS PRIVATE LIMITED holds the largest share at 19.4% (export value: $2.1M). Close behind, ANANTA MEDICARE LIMITED (9.6%, $1.0M). VENUS REMEDIES LIMITED (4.6%, $487.0K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ceftazidime? Top Manufacturers & Their Buyers
Flow of Ceftazidime from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ceftazidime Supplier Network — Key Market Intelligence
The Ceftazidime export market from India is led by ZEISS PHARMACEUTICALS PRIVATE LIMITED, which alone commands a 19.4% share, shipping $2.1M worth of product across 8 shipments. The second-largest exporter, ANANTA MEDICARE LIMITED, contributes $1.0M (9.6%) to the overall market. Combined, the top two suppliers alone account for 29.0% of all Ceftazidime exports, indicating a relatively concentrated supply base.
Across all 228 tracked manufacturers, the total Ceftazidime export value stands at $10.7M from 920 shipments. The market average shipment value is $11.6K. The single largest buyer relationship in terms of trade value is OA&J PHARMACEUTICALS LTD., receiving $2.0M worth of product.
The combined buyer network spans 14 named purchasing companies, including OA&J PHARMACEUTICALS LTD., OA & J PHARMACEUTICA, ANANTA MEDICARE UKRAINE LIMITED, MEDINOVA PHARMACEUTI, E P H K and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ZEISS PHARMACEUTICALS PRIVATE LIMITED
ZEISS PHARMACEUTICALS PRIVATE LIMITED is the first-largest Ceftazidime exporter from India, with a market share of 19.4% and a total export value of $2.1M across 8 shipments. Their average shipment value of $258.3K is above the market average of $11.6K, suggesting premium or bulk contract pricing.
ZEISS PHARMACEUTICALS PRIVATE LIMITED serves 4 named buyers in our database. OA&J PHARMACEUTICALS LTD. is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:
• OA&J PHARMACEUTICALS LTD. — $2.0M across 8 shipments (97.5% of this supplier's total exports)
• OA&J PHARMACEUTICALS LTD. — $36.4K across 0 shipments (1.8% of this supplier's total exports)
• OA & J PHARMACEUTICA — $8.1K across 0 shipments (0.4% of this supplier's total exports)
• OA&J PHARMACEUTICALS LTD. — $8.1K across 0 shipments (0.4% of this supplier's total exports)
Key Insight: ZEISS PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $258.3K is 2127% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.
2ANANTA MEDICARE LIMITED
ANANTA MEDICARE LIMITED is the second-largest Ceftazidime exporter from India, with a market share of 9.6% and a total export value of $1.0M across 21 shipments. Their average shipment value of $48.9K is above the market average of $11.6K, suggesting premium or bulk contract pricing.
ANANTA MEDICARE LIMITED serves 3 named buyers in our database. ANANTA MEDICARE UKRAINE LIMITED is the dominant customer, accounting for 62.9% of this supplier's tracked business. Top customers include:
• ANANTA MEDICARE UKRAINE LIMITED — $645.5K across 13 shipments (62.9% of this supplier's total exports)
• ANANTA MEDICARE UKRAINE LIMITED — $362.0K across 7 shipments (35.3% of this supplier's total exports)
• MEDINOVA PHARMACEUTI — $18.4K across 0 shipments (1.8% of this supplier's total exports)
Key Insight: ANANTA MEDICARE LIMITED's per-shipment value of $48.9K is 321% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.
3VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the third-largest Ceftazidime exporter from India, with a market share of 4.6% and a total export value of $487.0K across 73 shipments. Their average shipment value of $6.7K is below the market average of $11.6K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E P H K — $174.3K across 26 shipments (35.8% of this supplier's total exports)
• V P G — $137.7K across 21 shipments (28.3% of this supplier's total exports)
• I S P L — $84.5K across 13 shipments (17.3% of this supplier's total exports)
• P C L — $45.4K across 7 shipments (9.3% of this supplier's total exports)
• MINISTRY OF HEALTH S — $45.0K across 7 shipments (9.2% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (73 shipments) at a per-shipment value of $6.7K, indicating a broad distribution network with many smaller, regular orders.
4BIOCOLL PHARMACEUTICALS PRIVATE LIMITED
BIOCOLL PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Ceftazidime exporter from India, with a market share of 1.9% and a total export value of $201.3K across 4 shipments. Their average shipment value of $50.3K is above the market average of $11.6K, suggesting premium or bulk contract pricing.
BIOCOLL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. BIOMEDIC HEALTHCARE SOLUTION is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• BIOMEDIC HEALTHCARE SOLUTION — $201.3K across 4 shipments (100.0% of this supplier's total exports)
Key Insight: BIOCOLL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $50.3K is 334% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.
5SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI
SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI is the fifth-largest Ceftazidime exporter from India, with a market share of 1.7% and a total export value of $176.5K across 12 shipments. Their average shipment value of $14.7K is above the market average of $11.6K, suggesting premium or bulk contract pricing.
SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI serves 3 named buyers in our database. TO THE DIRECTOR OF is the dominant customer, accounting for 56.9% of this supplier's tracked business. Top customers include:
• TO THE DIRECTOR OF — $100.5K across 7 shipments (56.9% of this supplier's total exports)
• TO THE DIRECTOR OF — $69.0K across 5 shipments (39.1% of this supplier's total exports)
• TO THE DIRECTOR — $7.0K across 0 shipments (4.0% of this supplier's total exports)
Key Insight: SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI's per-shipment value of $14.7K is 27% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.
6THEON PHARMACEUTICALS LIMITED
THEON PHARMACEUTICALS LIMITED is the fifth-largest Ceftazidime exporter from India, with a market share of 1.0% and a total export value of $103.8K across 23 shipments. Their average shipment value of $4.5K is below the market average of $11.6K, reflecting a high-volume, competitive pricing strategy.
THEON PHARMACEUTICALS LIMITED serves 4 named buyers in our database. SYNER-MED PHARMACEUT is the dominant customer, accounting for 59.7% of this supplier's tracked business. Top customers include:
• SYNER-MED PHARMACEUT — $62.0K across 14 shipments (59.7% of this supplier's total exports)
• SYNER-MED PHARMACEUT — $27.5K across 6 shipments (26.4% of this supplier's total exports)
• GREEN CORE PHARMA IN — $7.6K across 2 shipments (7.3% of this supplier's total exports)
• GREEN CORE PHARMA IN — $6.8K across 2 shipments (6.6% of this supplier's total exports)
Key Insight: THEON PHARMACEUTICALS LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $4.5K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Ceftazidime Flows
Once Ceftazidime leaves the manufacturing plants of companies like ZEISS PHARMACEUTICALS PRIVATE LIMITED and ANANTA MEDICARE LIMITED, it travels to 5 destination markets with a combined import value of $10.7M. Ghana absorbs the largest share at 19.5% ($2.1M), followed by Ukraine (14.3%) and Sudan (8.0%).
In Ghana — the top destination — named importers include OA&J PHARMACEUTICALS LTD.. In Ukraine, key buyers are ANANTA MEDICARE UKRAINE LTD., ANANTA MEDICARE UKRAINE LIMITED.
This geographic spread reflects Ceftazidime's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ceftazidime Go? Top Importing Countries & Their Buyers
Trade flow of Ceftazidime exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Ghana
Ghana ranks as the first-largest destination for Ceftazidime imports from India, with a total trade value of $2.1M across 3 shipments — representing a 19.5% share of all Ceftazidime exports. The average shipment value of $694.5K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftazidime importers in Ghana: OA&J PHARMACEUTICALS LTD. is the largest buyer, accounting for 97.2% ($2.0M) of this market's total imports.
• OA&J PHARMACEUTICALS LTD. — $2.0M (97.2% of Ghana's total)
Key Insight: Ghana's per-shipment average of $694.5K (5887% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ghana is a key market for Ceftazidime imports from India.
2Ukraine
Ukraine ranks as the second-largest destination for Ceftazidime imports from India, with a total trade value of $1.5M across 18 shipments — representing a 14.3% share of all Ceftazidime exports. The average shipment value of $84.8K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ceftazidime importers in Ukraine: ANANTA MEDICARE UKRAINE LTD. is the largest buyer, accounting for 78.9% ($1.2M) of this market's total imports.
• ANANTA MEDICARE UKRAINE LTD. — $1.2M (78.9% of Ukraine's total)
• ANANTA MEDICARE UKRAINE LIMITED — $362.0K (23.7% of Ukraine's total)
Key Insight: Ukraine's per-shipment average of $84.8K (631% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ukraine is a key market for Ceftazidime imports from India.
3Sudan
Sudan ranks as the third-largest destination for Ceftazidime imports from India, with a total trade value of $850.9K across 3 shipments — representing a 8.0% share of all Ceftazidime exports. The average shipment value of $283.6K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftazidime importers in Sudan: TO THE DIRECTOR OF is the largest buyer, accounting for 11.8% ($100.5K) of this market's total imports.
• TO THE DIRECTOR OF — $100.5K (11.8% of Sudan's total)
Key Insight: Sudan's per-shipment average of $283.6K (2345% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sudan is a key market for Ceftazidime imports from India.
4France
France ranks as the fourth-largest destination for Ceftazidime imports from India, with a total trade value of $416.6K across 17 shipments — representing a 3.9% share of all Ceftazidime exports. The average shipment value of $24.5K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Ceftazidime importers in France: PLANETPHARMA SA is the largest buyer, accounting for 31.0% ($129.0K) of this market's total imports.
• PLANETPHARMA SA — $129.0K (31.0% of France's total)
• DISTRIMEX. — $95.0K (22.8% of France's total)
• DISTRIMEX PARC LOGISTIQUE DU PONT DE — $91.5K (22.0% of France's total)
Key Insight: France's per-shipment average of $24.5K (111% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Ceftazidime imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Ceftazidime imports from India, with a total trade value of $397.4K across 4 shipments — representing a 3.7% share of all Ceftazidime exports. The average shipment value of $99.3K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftazidime importers in Myanmar: BIOMEDIC HEALTHCARE SOLUTION is the largest buyer, accounting for 50.7% ($201.3K) of this market's total imports.
• BIOMEDIC HEALTHCARE SOLUTION — $201.3K (50.7% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $99.3K (757% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Ceftazidime imports from India.
People Also Ask — Ceftazidime Supplier & Trade Network
Who are the top suppliers of Ceftazidime from India?+
Which companies buy Ceftazidime from Indian manufacturers?+
Where does Ceftazidime exported from India go?+
What is the market share of the top Ceftazidime supplier from India?+
What is the average shipment value for Ceftazidime exports from India?+
Is Ceftazidime manufactured in India and exported globally?+
Which country imports the most Ceftazidime from India?+
Who are the buyers of Ceftazidime in Ukraine?+
How concentrated is the Ceftazidime supplier market in India?+
How do I find verified buyers for Ceftazidime in specific countries?+
Ceftazidime Trade Network — Key Takeaways
- 1ZEISS PHARMACEUTICALS PRIVATE LIMITED is India's dominant Ceftazidime exporter with a 19.4% market share and $2.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 228 suppliers collectively account for 38.1% of all tracked Ceftazidime exports, with a combined trade value of $10.7M.
- 3Ghana is the largest destination market, absorbing 19.5% of India's Ceftazidime exports ($2.1M). Ukraine (14.3%) and Sudan (8.0%) follow.
- 4With 920 total shipments averaging $11.6K each, the Ceftazidime export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include OA&J PHARMACEUTICALS LTD., OA&J PHARMACEUTICALS LTD., ANANTA MEDICARE UKRAINE LIMITED, ANANTA MEDICARE UKRAINE LIMITED — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 99 countries
Network value: $10.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ceftazidime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ceftazidime.
- 2.Flow Mapping: 228 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 920 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 99 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
920 Verified Shipments
228 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists